MC1194A1 - Benzylpyrimidines et procede pour leur preparation - Google Patents

Benzylpyrimidines et procede pour leur preparation

Info

Publication number
MC1194A1
MC1194A1 MC781301A MC1301A MC1194A1 MC 1194 A1 MC1194 A1 MC 1194A1 MC 781301 A MC781301 A MC 781301A MC 1301 A MC1301 A MC 1301A MC 1194 A1 MC1194 A1 MC 1194A1
Authority
MC
Monaco
Prior art keywords
group
formula
compound
alkyl group
groups
Prior art date
Application number
MC781301A
Other languages
English (en)
French (fr)
Inventor
I Kompis
A Wick
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU77269A external-priority patent/LU77269A1/xx
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1194A1 publication Critical patent/MC1194A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C07C45/66Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups by dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MC781301A 1977-05-05 1978-05-02 Benzylpyrimidines et procede pour leur preparation MC1194A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU77269A LU77269A1 (enExample) 1977-05-05 1977-05-05
CH265078A CH642637A5 (en) 1977-05-05 1978-03-10 Benzylpyrimidines and process for their preparation

Publications (1)

Publication Number Publication Date
MC1194A1 true MC1194A1 (fr) 1979-02-23

Family

ID=25691041

Family Applications (1)

Application Number Title Priority Date Filing Date
MC781301A MC1194A1 (fr) 1977-05-05 1978-05-02 Benzylpyrimidines et procede pour leur preparation

Country Status (19)

Country Link
US (2) US4203980A (enExample)
JP (1) JPS53137978A (enExample)
AT (1) ATA320578A (enExample)
BR (1) BR7802834A (enExample)
CA (1) CA1084498A (enExample)
DE (1) DE2819212A1 (enExample)
DK (1) DK143447C (enExample)
ES (1) ES469450A1 (enExample)
FI (1) FI781350A7 (enExample)
FR (1) FR2389611B1 (enExample)
GB (1) GB1583817A (enExample)
IL (1) IL54598A0 (enExample)
IT (1) IT1096292B (enExample)
MC (1) MC1194A1 (enExample)
NL (1) NL7804776A (enExample)
NO (1) NO781587L (enExample)
NZ (1) NZ187115A (enExample)
PT (1) PT67994B (enExample)
SE (1) SE7805186L (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
IT1138146B (it) * 1981-08-11 1986-09-17 Proter Spa Processo per la produzione della 2,4-diammino-(3,5-dimetossi-4-metos sietossi-benzil)-pirimidina
AU2007260356B2 (en) * 2006-06-16 2013-01-24 H. Lundbeck A/S Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) * 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
BE795023A (fr) * 1972-02-07 1973-08-06 Hoffmann La Roche Nouvelles benzylpyrimidines
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
US3931181A (en) * 1973-07-27 1976-01-06 Hoffmann-La Roche Inc. 2,4-Diamino-5-benzylpyrimidines
CH598231A5 (enExample) 1973-07-27 1978-04-28 Hoffmann La Roche
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes

Also Published As

Publication number Publication date
ES469450A1 (es) 1979-10-01
NO781587L (no) 1978-11-07
FR2389611A1 (enExample) 1978-12-01
JPS53137978A (en) 1978-12-01
BR7802834A (pt) 1979-02-13
ATA320578A (de) 1980-03-15
SE7805186L (sv) 1978-11-06
IT1096292B (it) 1985-08-26
NL7804776A (nl) 1978-11-07
US4203980A (en) 1980-05-20
PT67994A (en) 1978-06-01
IT7823093A0 (it) 1978-05-05
GB1583817A (en) 1981-02-04
DK143447B (da) 1981-08-24
IL54598A0 (en) 1978-07-31
DK143447C (da) 1982-01-04
DK195678A (da) 1978-11-06
DE2819212A1 (de) 1978-11-16
FR2389611B1 (enExample) 1980-06-20
PT67994B (en) 1980-05-05
CA1084498A (en) 1980-08-26
US4254286A (en) 1981-03-03
FI781350A7 (fi) 1978-11-06
NZ187115A (en) 1980-08-26

Similar Documents

Publication Publication Date Title
EP0399856B1 (fr) Pteridin-4 (3H)-ones, procédés de préparation et médicaments les contenant
EP0217700B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
MC1639A1 (fr) Derives de la glycerine
EP0045980B1 (fr) Composés utiles notamment pour la préparation d'aminopipéridines ayant des propriétés anorexigènes
MC894A1 (fr) Benzil-pyrimidines et leur préparations
MC1599A1 (fr) Nouveaux derives de pyrimidine
EP0117771B1 (fr) Imino-2 pyrrolidines, leur procédé de préparation et leurs applications en thérapeutique
FR2493315A1 (fr) Derive de piperazine, procede pour sa preparation et composition analgesique en contenant
CA1327364C (fr) ¬(diarylmethoxy)alcoyl|-1 pyrrolidines et piperidines, procede de preparation et medicaments les contenant
EP0239461A1 (fr) Dérivés de N-¬¬(hydroxy-2 phényl) (phényl) méthylène amino-2 éthyl acétamide, leur préparation et leur application en thérapeutique
FR2480284A1 (fr) Amines antihypertensives, leur procede de preparation et compositions antihypertensives en contenant.
EP0084993B1 (fr) Nouveaux dérivés de benzodioxine, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
FR2534582A1 (fr) Nouveaux derives de benzofuranne et de benzothiophene, utiles comme agents anti-hyperuricemie et anti-hypertension, et leur procede de fabrication
MC1194A1 (fr) Benzylpyrimidines et procede pour leur preparation
CA1209995A (fr) Procede pour la preparation de composes de nicotinamide 1-oxyde n-substitue et de ses sels, et les composes et sels ainsi obtenus
US4870091A (en) 1,4-dihydropyridine compounds
EP0338937B1 (fr) Dérivés du [(hydroxy-4 phényl)-3 hydroxy-1 propyl-1]-1 benzène substitué en position 2 par une chaîne amino-alkylèneoxy, leur procédé de préparation et leur application en thérapeutique
BE779775A (fr) Derives de l'uree, procede pour les preparer et leurs applications
FR2522000A1 (fr) Nouvelles thiopyrannopyrimidines, utiles notamment comme agents hypoglycemiants, et leur fabrication
MC1222A1 (fr) Nouvelles 2,4-diamino-5-benzylpyrimidines,leur preparation et leur application en tant que medicaments
EP0005091B1 (fr) Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
FR2576900A1 (fr) Derives de cyclohepto-imidazole 2-substitue, agents anti-ulcereux et procede pour leur preparation
EP0294258A1 (fr) Dérivés d'hydrazine, procédé d'obtention et compositions pharmaceutiques les contenant
EP0105881B1 (fr) Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
EP0713865B1 (fr) Dérivés d'acide 2-aminobenzènesulfonique et de chlorure de 2-aminobenzènesulfonyle, leur préparation et leur utilisation comme intermédiaires de synthèse

Legal Events

Date Code Title Description
YP Annual fee paid